Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health

ISSN: 2212-4055 (Online)
ISSN: 1871-5281 (Print)

Volume 15, 6 Issues, 2016

Download PDF Flyer

Inflammation & Allergy - Drug Targets (Discontinued)

Formerly: 'Current Drug Targets - Inflammation & Allergy

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Kurt S Zaenker
Institute of Immunology and Experimental Oncology
University Witten/Herdecke
Stockumerstraße 10
Witten, 58448

View Full Editorial Board

Purchase Articles Order Reprints

Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health

Inflammation & Allergy - Drug Targets (Discontinued), 13(2): 94-104.

Author(s): Enayat Nikoopour and Bhagirath Singh.

Affiliation: Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5C1, Canada.


Adaptation of the whole microbial normal flora residing in a host to its natural habitat over an evolutionary peroid has resulted in peaceful coexistence with mutual benefits for both microbiota and host in steady state. This symbiotic relationship between host and microbiota has a significant impact on shaping the immune response in the host to achieve an immune tolerance to microbiota but retaining the ability to respond to invading pathogens. Perturbation of this balance by manipulation of microbial communities in the host can lead to immune dysregulation and susceptibility to diseases. By studying the host in the absence of microbiota or with alteration of microbiota the complexity of microbial impact on the immune system can be resolved. Conversely, the study of microbiota in the absence of immune system factors can show how the immune system contributes to preservation of the host-microbiota balance. The absence of molecules involved in innate or adaptive immunity in knockout models can perturb the balance between host and microbiota further adding to more immune dysregulation. A better understanding of Microbiome-immune system interaction provides a new opportunity to identify biomarkers and drug targets. This will allow the development of new therapeutic agents for modulating the immune system to improve health with little or no toxicity. The study of interplay between host and microbiota has a promising role in the design of therapeutic interventions for immunopathological diseases arising from imbalanced host and microbiota interactions.


Adaptive and innate immunity, autoimmunity, helper T cells, immune regulation, immune system, microbial diversity, microbiome, probiotics.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 2
First Page: 94
Last Page: 104
Page Count: 11
DOI: 10.2174/1871528113666140330201056
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science